UBS AM
ADNT icon

UBS AM’s Adient ADNT Stock Holding History

UBS AM’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Sell
3,808
-142,742
-97% -$3.05M ﹤0.01% 2881
2026
Q1 		$2.96M Sell
146,550
-1,997
-1% -$44.4K ﹤0.01% 1840
2025
Q4 		$2.85M Sell
148,547
-5,779
-4% -$122K ﹤0.01% 1734
2025
Q3 		$3.72M Sell
154,326
-103,670
-40% -$2.42M ﹤0.01% 1508
2025
Q2 		$5.02M Buy
257,996
+62,068
+32% +$917K ﹤0.01% 1701
2025
Q1 		$2.52M Sell
195,928
-173,107
-47% -$2.78M ﹤0.01% 1882
2024
Q4 		$6.36M Buy
369,035
+189,574
+106% +$3.79M ﹤0.01% 1479
2024
Q3 		$4.05M Buy
179,461
+71,651
+66% +$1.64M ﹤0.01% 1684
2024
Q2 		$2.66M Sell
107,810
-12,087
-10% -$343K ﹤0.01% 1840
2024
Q1 		$3.95M Sell
119,897
-265
-0.2% -$9.02K ﹤0.01% 1364
2023
Q4 		$4.37M Sell
120,162
-1,596
-1% -$54.8K ﹤0.01% 1311
2023
Q3 		$4.47M Buy
121,758
+2,848
+2% +$114K ﹤0.01% 1256
2023
Q2 		$4.87M Hold
118,910
– – ﹤0.01% 1240
2023
Q1 		$4.87M Buy
118,910
+2,165
+2% +$90.4K ﹤0.01% 1240
2022
Q4 		$4.05M Buy
116,745
+9,944
+9% +$348K ﹤0.01% 1234
2022
Q3 		$2.96M Sell
106,801
-23,926
-18% -$776K ﹤0.01% 1396
2022
Q2 		$3.87M Sell
130,727
-4,918
-4% -$165K ﹤0.01% 1309
2022
Q1 		$5.53M Buy
135,645
+2,074
+2% +$89.1K ﹤0.01% 1309
2021
Q4 		$6.4M Sell
133,571
-52,351
-28% -$2.35M ﹤0.01% 1301
2021
Q3 		$7.71M Buy
185,922
+44,216
+31% +$1.76M ﹤0.01% 1190
2021
Q2 		$6.41M Buy
141,706
+6,470
+5% +$303K ﹤0.01% 1268
2021
Q1 		$5.98M Sell
135,236
-20,361
-13% -$769K ﹤0.01% 1269
2020
Q4 		$5.41M Buy
155,597
+2,492
+2% +$70.3K ﹤0.01% 1261
2020
Q3 		$2.65M Buy
153,105
+2,159
+1% +$37.6K ﹤0.01% 1431
2020
Q2 		$2.48M Sell
150,946
-14,340
-9% -$218K ﹤0.01% 1439
2020
Q1 		$1.5M Sell
165,286
-911
-0.5% -$18.3K ﹤0.01% 1539
2019
Q4 		$3.53M Buy
166,197
+9,920
+6% +$220K ﹤0.01% 1337
2019
Q3 		$3.59M Sell
156,277
-54,180
-26% -$1.24M ﹤0.01% 1344
2019
Q2 		$5.11M Buy
210,457
+1,611
+0.8% +$33.1K ﹤0.01% 1201
2019
Q1 		$2.71M Buy
208,846
+39,926
+24% +$699K ﹤0.01% 1380
2018
Q4 		$2.54M Buy
168,920
+29,733
+21% +$769K ﹤0.01% 1332
2018
Q3 		$5.47M Buy
139,187
+1,010
+0.7% +$45.5K ﹤0.01% 1120
2018
Q2 		$6.8M Sell
138,177
-15,875
-10% -$901K 0.01% 1051
2018
Q1 		$9.21M Buy
154,052
+26,359
+21% +$1.76M 0.01% 949
2017
Q4 		$10M Buy
127,693
+13,735
+12% +$1.11M 0.01% 924
2017
Q3 		$9.57M Buy
113,958
+14,010
+14% +$993K 0.01% 915
2017
Q2 		$6.53M Buy
99,948
+10,959
+12% +$745K 0.01% 981
2017
Q1 		$6.47M Buy
88,989
+88,891
+90,705% +$5.84M 0.01% 978
2016
Q4 		$6K Buy
+98
New +$5.17K ﹤0.01% 2409

Other funds holding ADNT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.83B AUM 34.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's ADNT Position: Q2 2026 in Review

UBS AM reduced its Adient (ADNT) stake by 97% in Q2 2026, selling an estimated $3.05M and leaving 3,808 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

UBS AM first reported a position in ADNT in Q4 2016 and has held it in 39 quarters since. The position peaked at $10M in Q4 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • UBS AM held 3,808 shares of Adient worth $70K as of Q2 2026.
  • UBS AM sold 142,742 Adient shares in Q2 2026, an estimated $3.05M.
  • Adient made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2881 holding.
  • UBS AM first reported a position in Adient in Q4 2016 and has held it in 39 quarters since.
  • UBS AM's Adient position peaked at $10M in Q4 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.